Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 103Terminated 22Active not recruiting 16Recruiting 15Withdrawn 8Unknown 5Suspended 2No longer available 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroblastoma 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

blinatumomab 10Cyclophosphamide 6fludarabine 4Vincristine 4Methotrexate 4Dexamethasone 4Cytarabine 4venetoclax 3Whole-Body Irradiation 2Thiotepa 2Therapeutics 2Mercaptopurine 2Exercise 2Busulfan 2ruxolitinib 1revumenib 1ponatinib 1pegaspargase 1olverembatinib 1navitoclax 1fludarabine phosphate 1etoposide phosphate 1capivasertib 1asciminib 1Ultrasonography 1Transplantation 1Prednisolone 1Melphalan 1Levofloxacin 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × fludarabine phosphate × Clear all
NCT05565105 2026-03-03

CD34+ Transplants for Leukemia and Lymphoma

Baptist Health South Florida

Phase 2 Not yet recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡